000 01558 a2200397 4500
005 20250514183651.0
264 0 _c20041028
008 200410s 0 0 eng d
022 _a1023-3830
024 7 _a10.1007/s00011-003-1230-4
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aGrosios, K
245 0 0 _aAngiogenesis inhibition by the novel VEGF receptor tyrosine kinase inhibitor, PTK787/ZK222584, causes significant anti-arthritic effects in models of rheumatoid arthritis.
_h[electronic resource]
260 _bInflammation research : official journal of the European Histamine Research Society ... [et al.]
_cApr 2004
300 _a133-42 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAngiogenesis Inhibitors
_xpharmacology
650 0 4 _aAnimals
650 0 4 _aArthritis, Rheumatoid
_xdrug therapy
650 0 4 _aCollagen
_ximmunology
650 0 4 _aFemale
650 0 4 _aHyperalgesia
_xdrug therapy
650 0 4 _aMale
650 0 4 _aMice
650 0 4 _aMice, Inbred DBA
650 0 4 _aPhthalazines
_xpharmacology
650 0 4 _aPyridines
_xpharmacology
650 0 4 _aRats
650 0 4 _aReceptors, Vascular Endothelial Growth Factor
_xantagonists & inhibitors
700 1 _aWood, J
700 1 _aEsser, R
700 1 _aRaychaudhuri, A
700 1 _aDawson, J
773 0 _tInflammation research : official journal of the European Histamine Research Society ... [et al.]
_gvol. 53
_gno. 4
_gp. 133-42
856 4 0 _uhttps://doi.org/10.1007/s00011-003-1230-4
_zAvailable from publisher's website
999 _c14776617
_d14776617